Maculopathy causes a decreased central vision, making it difficult to drive, read and face recognition. Maculopathy often affects old people and so it is frequently associated with cataract.
When maculopathy and cataract are experienced together, it is best to cure maculopathy first, and then move onto cataract; this is because vision lost because of maculopathy is hard to restore, while vision lost because of cataract can be easily restored after surgery.
Today, there are intraocular lenses especially developed for patients with advanced maculopathy and cataract, that can significantly improve vision enlarging the image and moving it on a healthy portion of the retina.
Maculopathy in fact, affects the central part of the retina (called macula), but portions around are perfectly healthy. Moving the image with this lens improves vision.
The latest innovation in curing maculopathy and cataract is the new intraocular lens called iolAMD, that is composed of two intraocular lenses, placed inside the eye during standard cataract surgery.
This lenses have a sophisticated geometry and function just like a galilean telescope that enlarges the image of 1.3 times and moves it on a healthy portion of the retina; this portion then replaced the functionality of the macula. Depending on the disease degree, patients can also start reading or driving again after surgery.
This surgery that cures both maculopathy and cataract can be compared to cataract surgery; it lasts for about 10 minutes and is performed with topic anesthesia, using a collyrium.
Dr. Badalà contributed developing this lens and is the first italian surgeon that used it. In September 2014, he showed the first usage data during the European Cataract Surgery Convention (ESCRS).